Litigation

Recent Posts

D.C. Circuit Says FDA Can Regulate Stem Cell Drugs; Company Properly Enjoined
Posted on 4 Feb 2014 by Tom Moylan

WASHINGTON, D.C. — The District of Columbia Circuit U.S. Court of Appeals on Feb. 4 said the federal government can regulate a company that cultures stem cells for injection in the donor patient and said a lower court did not err in permanently... Read More

Tags: drugs , Dr. Christopher Centeno , Food and Drug Administration , stem cells , LLC. , FDA , Michelle Cheever , mesenchymal stem cells , medical devices , Regenerative Sciences LLC , Cultured Regenexx Procedure , Dr. John Schultz , Litigation , District of Columbia Circuit U.S. Court of Appeals , United States of America v. Regenerative Sciences , MSCs